Host factors in the alphavirus replication complex

甲病毒复制复合物中的宿主因子

基本信息

  • 批准号:
    7185849
  • 负责人:
  • 金额:
    $ 32.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection of humans and other mammals by members of the Alphavirus genus within the Togaviridae can result in fever, rash, arthritis, encephalitis and death. Several alphaviruses have been designated by the Centers for Disease Control and Prevention as Category B agents of concern for possible use in bioterrorism, and as Priority Pathogens by the NIAID. There is currently no specific treatment available for diseases caused by these pathogens. We are studying Alphavirus replication with the long-term goal of identifying potential therapeutic targets. Replication of incoming positive-sense genomic RNA, which occurs in membrane-associated complexes containing the viral nonstructural proteins (nsPs), first generates a minus strand copy, followed by new progeny plus strand RNAs. We hypothesize that in addition to known differences in the viral nsP components of the minus and plus strand replicases, that recruitment of different host factors facilitates their disparate functions. We also hypothesize that alphaviruses utilize a common strategy of host factor recruitment to replicate their respective genomes. Using mutants expressing a tagged nsP3 protein, we propose to use immunological techniques to isolate the plus and minus strand replicases from three representative alphaviruses, Sindbis virus, Ross River virus, and Venezuelan equine encephalitis virus. The host factors present in the replication complexes will be identified by proteomic techniques. Focusing on factors commonly present in the Alphavirus plus and/or minus strand replicase complexes, we will verify each factor's association with the replicase in intact cells using confocal fluorescence microscopy. Using molecular and biochemical approaches, we will assess the effects of associated host components on viral replication and map the protein-protein (or protein-RNA) interactions of the host factors. Understanding the components of and molecular interactions within the Alphavirus minus and plus strand replicases will facilitate future exploration for inhibitors of these important pathogens.
描述(由申请人提供):披膜病毒科甲病毒属成员感染人类和其他哺乳动物可导致发热、皮疹、关节炎、脑炎和死亡。几种甲病毒已被疾病控制和预防中心指定为可能用于生物恐怖主义的关注B类试剂,并被NIAID指定为优先病原体。目前还没有针对这些病原体引起的疾病的具体治疗方法。 我们正在研究甲病毒的复制,其长期目标是确定潜在的治疗靶点。在含有病毒非结构蛋白(nsPs)的膜相关复合物中发生的传入的正义基因组RNA的复制首先产生负链拷贝,然后是新的子代正链RNA。 我们假设,除了已知的负链和正链复制酶的病毒nsP组分的差异,不同宿主因子的募集促进了它们不同的功能。 我们还假设甲病毒利用宿主因子招募的共同策略来复制其各自的基因组。 使用表达标记nsP 3蛋白的突变体,我们建议使用免疫学技术从三种代表性甲病毒(辛德比斯病毒、罗斯河病毒和委内瑞拉马脑炎病毒)中分离正链和负链复制酶。复制复合物中存在的宿主因子将通过蛋白质组学技术鉴定。 聚焦于甲病毒正链和/或负链复制酶复合物中常见的因子,我们将使用共聚焦荧光显微镜验证每个因子与完整细胞中复制酶的关联。 使用分子和生物化学方法,我们将评估相关的主机组件对病毒复制的影响,并绘制主机因子的蛋白质-蛋白质(或蛋白质-RNA)相互作用。 了解甲病毒负链和正链复制酶的组成和分子相互作用将有助于未来探索这些重要病原体的抑制剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARGARET R MACDONALD其他文献

MARGARET R MACDONALD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARGARET R MACDONALD', 18)}}的其他基金

Powassan virus nanobodies from camelid monomeric variable antibody domains elicited by natural infection
自然感染引起的骆驼单体可变抗体域的波瓦桑病毒纳米抗体
  • 批准号:
    10043364
  • 财政年份:
    2020
  • 资助金额:
    $ 32.05万
  • 项目类别:
Powassan virus nanobodies from camelid monomeric variable antibody domains elicited by natural infection
自然感染引起的骆驼单体可变抗体域的波瓦桑病毒纳米抗体
  • 批准号:
    10192656
  • 财政年份:
    2020
  • 资助金额:
    $ 32.05万
  • 项目类别:
Upregulation of ZAP expression as a novel approach for anti-alphavirus therapy
ZAP 表达上调作为抗甲病毒治疗的新方法
  • 批准号:
    8420421
  • 财政年份:
    2012
  • 资助金额:
    $ 32.05万
  • 项目类别:
Genome wide siRNA screen for identifying host factors required for ZAP function
全基因组 siRNA 筛选,用于鉴定 ZAP 功能所需的宿主因子
  • 批准号:
    8289157
  • 财政年份:
    2012
  • 资助金额:
    $ 32.05万
  • 项目类别:
Upregulation of ZAP expression as a novel approach for anti-alphavirus therapy
ZAP 表达上调作为抗甲病毒治疗的新方法
  • 批准号:
    8298821
  • 财政年份:
    2012
  • 资助金额:
    $ 32.05万
  • 项目类别:
Genome wide siRNA screen for identifying host factors required for ZAP function
全基因组 siRNA 筛选,用于鉴定 ZAP 功能所需的宿主因子
  • 批准号:
    8434103
  • 财政年份:
    2012
  • 资助金额:
    $ 32.05万
  • 项目类别:
Host factor DNAJC14 as a novel target for broad spectrum anti-flavivirus activity
宿主因子 DNAJC14 作为广谱抗黄病毒活性的新靶标
  • 批准号:
    8132747
  • 财政年份:
    2010
  • 资助金额:
    $ 32.05万
  • 项目类别:
Development of a genetically tractable nematode model of alphavirus infection
甲病毒感染的遗传易驯化线虫模型的开发
  • 批准号:
    7661284
  • 财政年份:
    2009
  • 资助金额:
    $ 32.05万
  • 项目类别:
Development of a genetically tractable nematode model of alphavirus infection
甲病毒感染的遗传易驯化线虫模型的开发
  • 批准号:
    7764768
  • 财政年份:
    2009
  • 资助金额:
    $ 32.05万
  • 项目类别:
Studies on ZAP, a broad-spectrum alphavirus inhibitor
广谱甲病毒抑制剂ZAP的研究
  • 批准号:
    7019145
  • 财政年份:
    2005
  • 资助金额:
    $ 32.05万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 32.05万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 32.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了